Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||
| Earning before tax | ---- | 51.87%44.89M | 39.96%24.36M | ---- | -30.26%29.55M | --17.41M | 30.87%42.38M | --32.38M |
| Profit adjustment | ||||||||
| Interest (income) - adjustment | ---- | -18.70%-971K | 26.78%-495K | ---- | -90.23%-818K | ---676K | -2,050.00%-430K | ---20K |
| Interest expense - adjustment | ---- | 25.01%2.83M | 2.90%1.7M | ---- | 23.59%2.26M | --1.65M | 93.96%1.83M | --944K |
| Impairment and provisions: | ---- | -418.26%-3.47M | -752.64%-3.09M | ---- | -80.28%1.09M | --473K | -10.49%5.53M | --6.18M |
| -Impairmen of inventory (reversal) | ---- | -456.32%-3.3M | -961.13%-3.19M | ---- | -83.29%925K | ---301K | -6.38%5.53M | --5.91M |
| -Other impairments and provisions | ---- | -204.85%-173K | -86.18%107K | ---- | 2,850.00%165K | --774K | -102.26%-6K | --265K |
| Revaluation surplus: | ---- | -76.41%838K | 16.89%976K | ---- | 459.98%3.55M | --835K | -168.94%-987K | ---367K |
| -Other fair value changes | ---- | -76.41%838K | 16.89%976K | ---- | 459.98%3.55M | --835K | -168.94%-987K | ---367K |
| Asset sale loss (gain): | ---- | --84K | --77K | ---- | ---- | ---- | --98K | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | --84K | --77K | ---- | ---- | ---- | --98K | ---- |
| Depreciation and amortization: | ---- | 18.14%10.88M | 11.35%7.88M | ---- | 25.78%9.21M | --7.08M | -9.18%7.32M | --8.06M |
| -Amortization of intangible assets | ---- | 34.57%5.24M | 56.72%3.78M | ---- | 66.78%3.9M | --2.41M | 18.34%2.34M | --1.97M |
| -Other depreciation and amortization | ---- | --900K | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | 103.49%8.16M | --4.01M |
| Adjustment items | ---- | --900K | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit before the change of operating capital | ---- | 24.80%55.97M | 17.35%31.42M | ---- | -29.81%44.85M | --26.77M | 24.84%63.9M | --51.19M |
| Change of operating capital | ||||||||
| Inventory (increase) decrease | ---- | 1,277.62%26.04M | 84.50%21.22M | ---- | -92.81%1.89M | --11.5M | 153.85%26.27M | ---48.79M |
| Accounts receivable (increase)decrease | ---- | 83.90%-5.8M | 143.69%8.6M | ---- | -641.48%-36.04M | ---19.69M | 151.95%6.66M | ---12.81M |
| Accounts payable increase (decrease) | ---- | -167.33%-19.2M | -1,765.75%-29.23M | ---- | 195.49%28.51M | --1.76M | -237.62%-29.85M | --21.69M |
| prepayments (increase)decrease | ---- | 135.31%1.73M | 352.12%5.12M | ---- | -222.84%-4.89M | ---2.03M | 139.63%3.98M | ---10.05M |
| Special items for working capital changes | ---- | 44.14%-2.59M | 58.14%-4.9M | ---- | 34.84%-4.64M | ---11.71M | -137.69%-7.12M | --18.89M |
| Cash from business operations | -287.64%-29.16M | 89.23%56.15M | 388.52%32.22M | --15.54M | -53.52%29.67M | --6.6M | 217.41%63.84M | --20.11M |
| Other taxs | 48.22%-2.13M | 53.90%-2.45M | 4.64%-4.52M | ---4.1M | -54.47%-5.32M | ---4.74M | 13.56%-3.44M | ---3.98M |
| Interest received - operating | -59.65%255K | 467.07%930K | 243.94%454K | --632K | 310.00%164K | --132K | 100.00%40K | --20K |
| Net cash from operations | -357.12%-31.03M | 122.79%54.63M | 1,318.14%28.15M | --12.07M | -59.43%24.52M | --1.99M | 274.22%60.44M | --16.15M |
| Cash flow from investment activities | ||||||||
| Loan receivable (increase) decrease | -3,588.37%-1.5M | -99.40%43K | -96.27%84K | --43K | 118.68%7.22M | --2.25M | ---38.64M | ---- |
| Sale of fixed assets | 241.57%4.7M | -22.22%7K | -66.67%3K | --1.38M | -92.86%9K | --9K | 12,500.00%126K | --1K |
| Purchase of fixed assets | -401.87%-32.53M | 45.52%-8.11M | 44.95%-6.96M | ---6.48M | 60.76%-14.89M | ---12.64M | 46.46%-37.95M | ---70.89M |
| Purchase of intangible assets | 45.75%-2.88M | 21.52%-8.5M | 20.47%-7.23M | ---5.3M | -39.87%-10.83M | ---9.09M | -239.74%-7.75M | ---2.28M |
| Recovery of cash from investments | 33.02%123.03M | -28.09%259.77M | -50.78%155.6M | --92.49M | -35.74%361.26M | --316.12M | 41.54%562.19M | --397.2M |
| Cash on investment | -10.29%-127.71M | 13.36%-271.34M | 32.65%-176.3M | ---115.79M | 45.75%-313.17M | ---261.77M | -37.15%-577.28M | ---420.92M |
| Net cash from investment operations | -9.55%-36.88M | -195.10%-28.13M | -199.77%-34.8M | ---33.67M | 129.79%29.58M | --34.88M | -2.49%-99.3M | ---96.88M |
| Net cash before financing | -214.40%-67.91M | -51.02%26.5M | -118.04%-6.65M | ---21.6M | 239.22%54.1M | --36.87M | 51.86%-38.86M | ---80.73M |
| Cash flow from financing activities | ||||||||
| New borrowing | 80.00%72M | 104.42%86.58M | 114.81%58M | --40M | -38.71%42.35M | --27M | 19.95%69.1M | --57.61M |
| Refund | -35.77%-15.71M | -28.41%-84.02M | 35.79%-27.13M | ---11.57M | -293.81%-65.43M | ---42.25M | -10.77%-16.62M | ---15M |
| Issuing shares | --167.99M | ---- | ---- | ---- | ---- | ---- | ---- | --50.01M |
| Interest paid - financing | 10.07%-1.21M | -7.28%-2.81M | -0.70%-1.73M | ---1.35M | -32.63%-2.62M | ---1.71M | -88.29%-1.98M | ---1.05M |
| Dividends paid - financing | ---- | 10.00%-31.5M | 10.00%-31.5M | ---1.5M | -600.00%-35M | ---35M | -316.67%-5M | ---1.2M |
| Issuance expenses and redemption of securities expenses | -811.79%-10.44M | -33.28%-2.29M | ---- | ---1.15M | ---1.72M | ---- | ---- | ---- |
| Adjustment item of financing business | ---- | ---- | 0.13%-1.56M | ---- | ---- | ---1.56M | ---- | ---- |
| Net cash from financing operations | 774.47%212.56M | 45.34%-34.3M | 92.00%-4.3M | --24.31M | -239.76%-62.75M | ---53.78M | -48.85%44.9M | --87.78M |
| Effect of rate | -792.75%-478K | -24.72%268K | 125.44%647K | --69K | -74.54%356K | --287K | 3,684.62%1.4M | ---39K |
| Net Cash | 5,243.48%144.65M | 9.74%-7.8M | 35.23%-10.95M | --2.71M | -243.22%-8.64M | ---16.91M | -14.40%6.03M | --7.05M |
| Begining period cash | -49.75%7.61M | -35.37%15.14M | -35.37%15.14M | --15.14M | 46.46%23.43M | --23.43M | 78.02%16M | --8.99M |
| Cash at the end | 747.12%151.78M | -49.75%7.61M | -28.94%4.83M | --17.92M | -35.37%15.14M | --6.8M | 46.46%23.43M | --16M |
| Cash balance analysis | ||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | PwC Accounting Firm | -- | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.